Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 18, 2022 | Post-IPO Equity | $140M | 3 | — | — | Detail |
Feb 4, 2021 | IPO | $258.31M | — | — | — | Detail |
Jan 11, 2021 | Series C | $75M | 1 | BlackRock | — | Detail |
Jan 11, 2021 | Debt Financing | $100M | 1 | Oxford Finance LLC | — | Detail |
Mar 2, 2020 | Series B | $130M | 9 | General Atlantic | — | Detail |
Sep 18, 2017 | Series B | $40M | 1 | Bill & Melinda Gates Foundation | — | Detail |
Jul 16, 2015 | Series A | $320M | 3 | Woodford Investment Management | — | Detail |
Nov 5, 2012 | Grant | £2.40M | 1 | Biomedical Catalyst Fund | — | Detail |